Alterity Therapeutics Ltd (ATH)

Alterity Therapeutics Ltd recorded a single insider purchase totaling 23,810 USD on August 31, 2026. Peter Ashley Marks acquired 47,620 shares following the company's latest results financiers. This activity occurs amidst a 50.5% decline in stock value over the past ninety days, with the current price trading near its fifty-two-week low.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Marks Peter Ashley Non-Executive Director
Transaction date
Purchase
Price
249.74
Quantity 68,050 +49.1%
Value US$3,732,374
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-08 2026-08-31 B Purchase Non-Executive Director
68,050 +49.1%
249.74
US$3,732,374
68,050 +49.1% 249.74 US$3,732,374